Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
54.38
+0.56 (1.04%)
At close: Jun 6, 2025, 4:00 PM
54.00
-0.38 (-0.70%)
After-hours: Jun 6, 2025, 7:38 PM EDT

Protagonist Therapeutics Market Cap

Protagonist Therapeutics has a market cap or net worth of $3.37 billion as of June 6, 2025. Its market cap has increased by 81.22% in one year.

Market Cap
3.37B
Enterprise Value
2.68B
1-Year Change
81.22%
Ranking
Category
Stock Price
$54.38

Market Cap Chart

Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $3.37B, an increase of 1,865.35%. That is a compound annual growth rate of 40.14%.

History

DateMarket Cap% Change
Jun 6, 20253.37B46.52%
Dec 31, 20242.30B73.94%
Dec 29, 20231.32B146.39%
Dec 30, 2022536.80M-67.11%
Dec 31, 20211.63B111.63%
Dec 31, 2020771.30M302.14%
Dec 31, 2019191.80M17.81%
Dec 31, 2018162.80M-61.78%
Dec 29, 2017426.00M15.89%
Dec 30, 2016367.60M114.34%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 687.38B
Johnson & Johnson 369.72B
AbbVie 331.15B
Novo Nordisk 324.15B
UnitedHealth Group 268.37B
Abbott Laboratories 233.03B
Novartis AG 230.96B
AstraZeneca 225.55B
Market Cap Rankings